Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;12(1):2919-2931.
doi: 10.1080/21505594.2021.2004743.

Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status

Celia Crespo-Bermejo  1 , Eva Ramírez de Arellano  1 , Violeta Lara-Aguilar  1 , Daniel Valle-Millares  1 , Mª Luisa Gómez-Lus  2 , Ricardo Madrid  3   4 , Luz Martín-Carbonero  5 , Verónica Briz  1
Affiliations
Review

Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status

Celia Crespo-Bermejo et al. Virulence. 2021 Dec.

Abstract

Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in most treated persons living with HIV (PLWH). However, the existence of PLWH that show events of persistent low-level viremia (pLLV) between 50 and 1000 copies/mL and with different virological consequences have been observed. PLLV has been associated with higher virological failure (VF), viral genotype resistance, adherence difficulties and AIDS events. Moreover, some reports show that pLLV status can lead to residual immune activation and inflammation, with an increased risk of immunovirological failure and a pro-inflammatory cytokine level which can lead to a higher occurrence of non-AIDS defining events (NADEs) and other adverse clinical outcomes. Until now, however, published data have shown controversial results that hinder understanding of the true cause(s) and origin(s) of this phenomenon. Molecular mechanisms related to viral reservoir size and clonal expansion have been suggested as the possible origin of pLLV. This review aims to assess recent findings to provide a global view of the role of pLLV in PLWH and the impact this status may cause on the clinical progression of these patients.

Keywords: ART adherence; HIV; VF; aids events and nades; clonal expansion; immune activation; mortality; pLLV; reservoir.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

References

    1. Thiébaut R, Morlat P, Jacqmin-Gadda H, et al. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d’Epidémiologie du SIDA en Aquitaine (GECSA). AIDS. 2000;14(8):971–978. - PubMed
    1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–860. - PubMed
    1. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807. - PMC - PubMed
    1. Guidelines for the use of antiretroviral agents in adults and adolescent living with HIV. https://aidsinfo-nih.gov/contentfiles/vguidelines/adultandadolescentgl.pdf. Accessed 2020 Jan 14
    1. EACS . European AIDS clinical society. European guidelines for treatment of HIV infected adults in Europe. Versión 10.0 2019. https://eacsociety.org/files/2019_guidelines-10.0_final.pdf. Accessed 2020 Jan 14

Publication types